Figure 2 Macular thickness changes on OCT map and ETDRS grids before and after intravitreal faricimab injection.(A) OCT thickness map at presentation showing prominent CME that extends from the superior parafoveal region to the foveal center. (B) ETDRS 9-sector grid at presentation showing pronounced thickening in the central and superior subfields. (C) OCT map 1 week after injection showing partial reduction of edema, particularly in the superior parafoveal region. (D) ETDRS grid 1 week after injection showing decreased thickness in the central and superior subfields, although overall thickness remains greater than normal. (E) OCT map 1 month after injection showing further reduction of edema in the superior parafoveal region; thickness remains elevated. (F) ETDRS grid 1 month after injection showing persistent but reduced thickening in the central and superior subfields. CME – cystoid macular edema; ETDRS – Early Treatment Diabetic Retinopathy Study; OCT – optical coherence tomography.